Ampligen

rintatolimod · AIM ImmunoTech Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Ampligen, covering 2013-04-17 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients [Phase 1, Phase 2]